XELJANZ (tofacitinib) tablets is used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis.

XELJANZ/XELJANZ XR is a Janus kinase (JAK) inhibitor. It is indicated for the treatment of adult patients with Rheumatoid Arthritis, Psoriatic Arthritis , Ulcerative Colitis.

Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.

Trade Name: XELJANZ (tofacitinib)

Generic Name: tofacitinib

XELJANZ Tablets: 5 mg, 10 mg tofacitinib
XELJANZ XR Tablets: 11 mg tofacitinib

XELJANZ (tofacitinib) tablets suppliers in India

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of XELJANZ (tofacitinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.

The order for XELJANZ (tofacitinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Xeljanz (tofacitinib)

with Indian Pharma Network

Indian Pharma Network, Delhi provides access to Xeljanz (tofacitinib) on the Named Patient Import basis in India.

Facilitator under Named Patient Supply.

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA. Indian Pharma Network (IPN) act as a facilitator for you, under Named Patient Supply for anti-cancer medicines.

For overseas patient " XELJANZ (tofacitinib) tablets " brands can be also made available to overseas patients, doctors and hospitals at China, Cambodia, Indonesia, Nepal, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

News / Update for XELJANZ (tofacitinib).

For XELJANZ (tofacitinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Xeljanz Eases Symptoms and Disease Flares in Children with Polyarticular JIA, Phase 3 Trial Shows For More Details

Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting. For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur